Regulus Therapeutics Inc. (RGLS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Regulus Therapeutics Inc.

    NASDAQ: RGLS · Real-Time Price · USD
    8.16
    0.00 (0.00%)
    At close: Jun 24, 2025, 3:59 PM

    Regulus Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 38.53M 23.77M 24.23M 60.38M
    Short-Term Investments
    		 37.25M n/a 14.93M n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a n/a 291K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a 3.01M 3.01M 3.01M
    Other Current Assets
    		 3.08M 62K 62K 62K
    Total Current Assets
    		 82.34M 28.18M 44.08M 65.23M
    Property-Plant & Equipment
    		 1.81M 2.54M 2.58M 2.85M
    Goodwill & Intangibles
    		 25K 33K 62K 83K
    Total Long-Term Assets
    		 1.84M 2.57M 2.64M 3.22M
    Total Assets
    		 84.18M 30.75M 46.72M 68.45M
    Account Payables
    		 947K 204K 175K 285K
    Deferred Revenue
    		 n/a n/a n/a -589K
    Short-Term Debt
    		 n/a 1.33M 4.51M 589K
    Other Current Liabilities
    		 5.04M 5.36M 2.55M 706K
    Total Current Liabilities
    		 7.5M 8.51M 11.66M 5.23M
    Long-Term Debt
    		 n/a n/a n/a 4.67M
    Other Long-Term Liabilities
    		 n/a n/a n/a 1.18M
    Total Long-Term Liabilities
    		 274K 1.05M 1.77M 8.27M
    Total Liabilities
    		 7.77M 9.56M 13.43M 13.5M
    Total Debt
    		 274K 2.39M 6.28M 7.09M
    Book Value
    		 76.41M 21.19M 33.29M 54.96M
    Book Value Per Share
    		 1.36 1.12 2.18 6.41
    Common Stock
    		 66K 20K 17K 146K
    Retained Earnings
    		 -559.57M -513.21M -483.18M -454.85M
    Comprehensive Income
    		 50K n/a -12K n/a
    Shareholders Equity
    		 76.41M 21.19M 33.29M 54.96M
    Total Investments
    		 37.25M n/a 14.93M n/a

    Add to Watchlist